Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

AZD6234

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese

AstraZeneca · Phase 1 · Completed · Enrollment 104

NCT06132841

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Cohort 1n/rn/rn/rn/r
Cohort 2n/rn/rn/rn/r
Cohort 3n/rn/rn/rn/r
Cohort 4n/rn/rn/rn/r

Not shown

  • Cohort 1: endpoint not reported
  • Cohort 2: endpoint not reported
  • Cohort 3: endpoint not reported
  • Cohort 4: endpoint not reported